Related Topics News -

     
 Title only   |   Print 
     
兆科眼科YUVEZZI滴眼液中國老花眼患者II期臨床達主要研究終點

2026-09-07T  
兆科眼科與澎湃生物醫藥 就商業化鹽酸依匹斯汀滴眼液訂立獨家分銷及推廣協議

2026-08-12T  
兆科眼科YUVEZZI獲澳門批准用於治療老花眼 正積極爭取加入港澳藥械通

2026-07-20T  
兆科眼科收購硫酸阿托品滴眼液全球權利

2026-07-13T  
兆科眼科老花眼創新藥YUVEZZI獲准於博鰲超級醫院作為臨床急需進口藥品使用

2026-07-07T  
兆科眼科:0.01%及0.02%濃度硫酸阿托品滴眼液註冊申請 均已獲澳洲藥品管理局受理評估

2026-06-15T  
兆科眼科擬斥最多1億元購回不多於5,487.49萬股

2026-06-09T  
兆科眼科與PT. ERELA就於印尼商業化環孢素眼用凝膠訂立分銷及供應協議

2026-06-05T  
兆科眼科料下半年多個產品申請陸續獲批 冀今年將國際網絡拓展至拉美或南美洲

2026-04-01T  
《業績》兆科眼科全年虧損收窄至2.09億人民幣

2026-03-25T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.